{"brief_title": "Study of Milnacipran for the Treatment of Fibromyalgia", "brief_summary": "Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia. The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.", "condition": "Fibromyalgia", "intervention_type": "Drug", "intervention_name": "milnacipran hydrochloride", "criteria": "Inclusion Criteria: - Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria Exclusion Criteria: - Psychiatric illness - Depression - Suicidal risk - Substance abuse - Pulmonary dysfunction - Renal impairment - Active cardiac disease - Liver disease - Autoimmune disease - Cancer - Sleep apnea - Inflammatory bowel disease", "gender": "All", "minimum_age": "18 Years", "maximum_age": "70 Years", "healthy_volunteers": "No", "id": "NCT00098124.xml"}